Literature DB >> 29373921

"Understanding my ALS". Experiences and reflections of persons with amyotrophic lateral sclerosis and relatives on participation in peer group rehabilitation.

Louise Sofia Madsen1,2, Jørgen Jeppesen3, Charlotte Handberg1,2.   

Abstract

PURPOSE: The aim of this study was to gain insight into experiences and reflections of persons with amyotrophic lateral sclerosis and relatives concerning the peer group rehabilitation programme "More Life - Less Illness".
METHODS: This qualitative study used the Interpretive Description methodology with Symbolic Interactionism as the analytical framework. Eighteen programme participants representing persons with amyotrophic lateral sclerosis (n = 8) and relatives (n = 10) were included. Data consisted of individual interviews and participant observation.
RESULTS: The analysis revealed two categorical themes, "Sense of Community Building" and "Understanding my ALS", which represented the participants' experiences and reflections on peer group rehabilitation. Through the analysis, it became apparent that "Sense of Community Building" gave rise to an increased and personalised understanding of amyotrophic lateral sclerosis among the participants. As a part of the continuous processing of the knowledge gained, "Facing Facts" and "Retaining Normality" appeared as subthemes regarding the participants' ability to live a less dependent and more meaningful life.
CONCLUSIONS: This study of peer group rehabilitation for persons with amyotrophic lateral sclerosis and relatives indicates that programme participation leads to positive experiences in terms of living a shared meaningful life despite severe disability. The findings may guide practice to develop longitudinal peer group rehabilitation programmes with joint inclusion of persons with amyotrophic lateral sclerosis and relatives. Implications for Rehabilitation Peer group rehabilitation may facilitate an increased and personalised understanding of what it means to live with amyotrophic lateral sclerosis. A programme design with six months of sequential sessions enables a continuous processing of shared experiences and gained knowledge. Joint participation of persons with amyotrophic lateral sclerosis and their relatives supports both their internal relationship and social networking. Peer group rehabilitation in amyotrophic lateral sclerosis should help overcome obstacles concerning the needs of participants, accessibility, and geographical distance.

Entities:  

Keywords:  Peer group; amyotrophic lateral sclerosis; interpretive description; rehabilitation; relatives; social support networking

Mesh:

Year:  2018        PMID: 29373921     DOI: 10.1080/09638288.2018.1429499

Source DB:  PubMed          Journal:  Disabil Rehabil        ISSN: 0963-8288            Impact factor:   3.033


  4 in total

1.  A cross-sectional evaluation of acceptability of an online palliative rehabilitation program for family caregivers of people with amyotrophic lateral sclerosis and cognitive and behavioral impairments.

Authors:  Lene Klem Olesen; Karen la Cour; Heidi With; Annette Faber Mahoney; Charlotte Handberg
Journal:  BMC Health Serv Res       Date:  2022-05-24       Impact factor: 2.908

2.  Prioritising target non-pharmacological interventions for research in Parkinson's disease: achieving consensus from key stakeholders.

Authors:  Angeliki Bogosian; Lorna Rixon; Catherine S Hurt
Journal:  Res Involv Engagem       Date:  2020-06-24

3.  Using the Concept of Health Literacy to Understand How People Living with Motor Neurone Disease and Carers Engage in Healthcare: A Longitudinal Qualitative Study.

Authors:  Camille Paynter; Susan Mathers; Heidi Gregory; Adam P Vogel; Madeline Cruice
Journal:  Healthcare (Basel)       Date:  2022-07-24

4.  Analysing the influencing factors on caregivers' burden among amyotrophic lateral sclerosis patients in China: a cross-sectional study based on data mining.

Authors:  Ling Lian; Minying Zheng; Ruojie He; Jianing Lin; Weineng Chen; Zhong Pei; Xiaoli Yao
Journal:  BMJ Open       Date:  2022-09-21       Impact factor: 3.006

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.